vs
Side-by-side financial comparison of FGI Industries Ltd. (FGI) and GYRE THERAPEUTICS, INC. (GYRE). Click either name above to swap in a different company.
GYRE THERAPEUTICS, INC. is the larger business by last-quarter revenue ($37.2M vs $30.5M, roughly 1.2× FGI Industries Ltd.). GYRE THERAPEUTICS, INC. runs the higher net margin — -3.7% vs -8.6%, a 5.0% gap on every dollar of revenue. On growth, GYRE THERAPEUTICS, INC. posted the faster year-over-year revenue change (33.4% vs -14.4%). FGI Industries Ltd. produced more free cash flow last quarter ($2.3M vs $-5.8M). Over the past eight quarters, GYRE THERAPEUTICS, INC.'s revenue compounded faster (17.0% CAGR vs -0.5%).
FGI Industries Ltd is a global designer, manufacturer and distributor of kitchen and bath products, home organization solutions, and home improvement goods. It serves major retail chains, home specialty stores and e-commerce platforms across North America, Europe and the Asia-Pacific region.
GYRE Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel targeted therapies for hard-to-treat hematologic malignancies and solid tumors. It focuses on precision oncology to address unmet patient needs, with operations primarily based in North America.
FGI vs GYRE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $30.5M | $37.2M |
| Net Profit | $-2.6M | $-1.4M |
| Gross Margin | 26.7% | 95.3% |
| Operating Margin | -2.2% | 0.3% |
| Net Margin | -8.6% | -3.7% |
| Revenue YoY | -14.4% | 33.4% |
| Net Profit YoY | -553.1% | -340.1% |
| EPS (diluted) | $-1.63 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.5M | $37.2M | ||
| Q3 25 | $35.8M | $30.6M | ||
| Q2 25 | $31.0M | $26.8M | ||
| Q1 25 | $33.2M | $22.1M | ||
| Q4 24 | $35.6M | $27.9M | ||
| Q3 24 | $36.1M | $25.5M | ||
| Q2 24 | $29.4M | $25.2M | ||
| Q1 24 | $30.8M | $27.2M |
| Q4 25 | $-2.6M | $-1.4M | ||
| Q3 25 | $-1.7M | $5.9M | ||
| Q2 25 | $-1.2M | $1.6M | ||
| Q1 25 | $-629.1K | $3.7M | ||
| Q4 24 | $-402.3K | $569.0K | ||
| Q3 24 | $-550.1K | $2.9M | ||
| Q2 24 | $163.6K | $4.5M | ||
| Q1 24 | $-412.2K | $9.9M |
| Q4 25 | 26.7% | 95.3% | ||
| Q3 25 | 26.5% | 94.7% | ||
| Q2 25 | 28.1% | 95.7% | ||
| Q1 25 | 26.8% | 95.9% | ||
| Q4 24 | 24.6% | 95.8% | ||
| Q3 24 | 25.8% | 96.2% | ||
| Q2 24 | 30.5% | 96.9% | ||
| Q1 24 | 27.4% | 96.4% |
| Q4 25 | -2.2% | 0.3% | ||
| Q3 25 | 1.0% | 22.7% | ||
| Q2 25 | -2.7% | 8.1% | ||
| Q1 25 | -3.9% | 10.3% | ||
| Q4 24 | -3.5% | 2.4% | ||
| Q3 24 | -0.2% | 16.6% | ||
| Q2 24 | -1.5% | 12.7% | ||
| Q1 24 | -1.0% | 29.7% |
| Q4 25 | -8.6% | -3.7% | ||
| Q3 25 | -4.6% | 19.4% | ||
| Q2 25 | -4.0% | 5.9% | ||
| Q1 25 | -1.9% | 16.9% | ||
| Q4 24 | -1.1% | 2.0% | ||
| Q3 24 | -1.5% | 11.2% | ||
| Q2 24 | 0.6% | 18.0% | ||
| Q1 24 | -1.3% | 36.6% |
| Q4 25 | $-1.63 | $-0.01 | ||
| Q3 25 | $-0.86 | $0.03 | ||
| Q2 25 | $-0.64 | $0.00 | ||
| Q1 25 | $-0.07 | $0.00 | ||
| Q4 24 | $-0.38 | $0.00 | ||
| Q3 24 | $-0.29 | $0.01 | ||
| Q2 24 | $0.08 | $0.01 | ||
| Q1 24 | $-0.04 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.9M | $52.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $17.3M | $106.0M |
| Total Assets | $69.5M | $166.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.9M | $52.4M | ||
| Q3 25 | $1.9M | $60.0M | ||
| Q2 25 | $2.5M | $54.4M | ||
| Q1 25 | $1.2M | $29.9M | ||
| Q4 24 | $4.6M | $26.7M | ||
| Q3 24 | $3.0M | $25.1M | ||
| Q2 24 | $1.3M | $25.1M | ||
| Q1 24 | $3.3M | $37.4M |
| Q4 25 | $17.3M | $106.0M | ||
| Q3 25 | $19.7M | $101.9M | ||
| Q2 25 | $21.3M | $92.0M | ||
| Q1 25 | $21.8M | $68.1M | ||
| Q4 24 | $22.3M | $63.3M | ||
| Q3 24 | $23.5M | $63.2M | ||
| Q2 24 | $23.8M | $60.4M | ||
| Q1 24 | $23.9M | $56.6M |
| Q4 25 | $69.5M | $166.1M | ||
| Q3 25 | $73.0M | $159.4M | ||
| Q2 25 | $71.7M | $152.6M | ||
| Q1 25 | $68.5M | $129.8M | ||
| Q4 24 | $75.5M | $125.4M | ||
| Q3 24 | $74.7M | $125.2M | ||
| Q2 24 | $69.9M | $120.9M | ||
| Q1 24 | $68.6M | $122.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.3M | $-5.6M |
| Free Cash FlowOCF − Capex | $2.3M | $-5.8M |
| FCF MarginFCF / Revenue | 7.5% | -15.5% |
| Capex IntensityCapex / Revenue | 0.2% | 0.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-212.5K | $-180.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.3M | $-5.6M | ||
| Q3 25 | $-1.9M | $4.7M | ||
| Q2 25 | $7.6M | $2.1M | ||
| Q1 25 | $-7.4M | $-129.0K | ||
| Q4 24 | $617.4K | $-2.8M | ||
| Q3 24 | $-915.0K | $1.7M | ||
| Q2 24 | $862.1K | $-5.5M | ||
| Q1 24 | $-8.0M | $2.9M |
| Q4 25 | $2.3M | $-5.8M | ||
| Q3 25 | $-2.1M | $4.0M | ||
| Q2 25 | $7.4M | $1.8M | ||
| Q1 25 | $-7.7M | $-251.0K | ||
| Q4 24 | $-214.1K | $-2.8M | ||
| Q3 24 | $-1.1M | $1.0M | ||
| Q2 24 | $281.5K | $-6.9M | ||
| Q1 24 | $-8.6M | $2.7M |
| Q4 25 | 7.5% | -15.5% | ||
| Q3 25 | -5.9% | 13.1% | ||
| Q2 25 | 23.8% | 6.8% | ||
| Q1 25 | -23.3% | -1.1% | ||
| Q4 24 | -0.6% | -10.1% | ||
| Q3 24 | -3.0% | 4.1% | ||
| Q2 24 | 1.0% | -27.5% | ||
| Q1 24 | -28.0% | 9.8% |
| Q4 25 | 0.2% | 0.4% | ||
| Q3 25 | 0.7% | 2.2% | ||
| Q2 25 | 0.7% | 1.0% | ||
| Q1 25 | 1.1% | 0.6% | ||
| Q4 24 | 2.3% | 0.2% | ||
| Q3 24 | 0.5% | 2.7% | ||
| Q2 24 | 2.0% | 5.8% | ||
| Q1 24 | 2.0% | 0.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.79× | ||
| Q2 25 | — | 1.32× | ||
| Q1 25 | — | -0.03× | ||
| Q4 24 | — | -4.85× | ||
| Q3 24 | — | 0.60× | ||
| Q2 24 | 5.27× | -1.21× | ||
| Q1 24 | — | 0.29× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FGI
| Sanitaryware | $19.1M | 63% |
| Shower System | $5.8M | 19% |
| Kitchen And Bath Other | $3.3M | 11% |
| Bath Furniture Products | $2.3M | 7% |
GYRE
Segment breakdown not available.
